Re: Efficacy of Everolimus in Advanced Renal Cell Carcinoma: A Double-Blind, Randomised, Placebo-Controlled Phase III Trial

被引：1
作者：
Pouliot, Frederic [1 ]
Pantuck, Allan J. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
来源：
EUROPEAN UROLOGY | 2009年 / 55卷 / 06期
关键词：
D O I：
10.1016/j.eururo.2009.03.034
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1482 / 1484
页数：3
相关论文
共 50 条
  • [41] Re: Dutasteride in Localised Prostate Cancer Management: The REDEEM Randomised, Double-Blind, Placebo-Controlled Trial
    Parsons, J. Kellogg
    EUROPEAN UROLOGY, 2013, 64 (01) : 167 - 167
  • [42] Cabergoline in advanced RLS: A double-blind, placebo-controlled, multicenter trial
    Stiasny-Kolster, K
    Ueberall, M
    Oertel, W
    MOVEMENT DISORDERS, 2002, 17 : S231 - S231
  • [43] The cult of the double-blind placebo-controlled trial
    Ellis, SJ
    Adams, RF
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1997, 51 (01): : 36 - 39
  • [44] Re: Dutasteride in Localised Prostate Cancer Management: The REDEEM Randomised, Double-blind, Placebo-controlled Trial
    Tombal, Bertrand
    Lecouvet, Frederic
    EUROPEAN UROLOGY, 2012, 61 (06) : 1265 - 1266
  • [45] Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial
    Kappos, Ludwig
    Arnold, Douglas L.
    Bar-Or, Amit
    Camm, John
    Derfuss, Tobias
    Kieseier, Bernd C.
    Sprenger, Till
    Greenough, Kristin
    Ni, Pingping
    Harada, Tomohiko
    LANCET NEUROLOGY, 2016, 15 (11) : 1148 - 1159
  • [46] A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch
    Murphy, M
    Reaich, D
    Pai, P
    Finn, P
    Carmichael, AJ
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (02) : 314 - 317
  • [47] Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial
    McCarey, DW
    McInnes, LB
    Madhok, R
    Hampson, R
    Scherbakova, O
    Ford, I
    Capell, HA
    Sattar, N
    LANCET, 2004, 363 (9426) : 2015 - 2021
  • [48] Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
    Tepper, Stewart
    Ashina, Messoud
    Reuter, Uwe
    Brandes, Jan L.
    Dolezil, David
    Silberstein, Stephen
    Winner, Paul
    Leonardi, Dean
    Mikol, Daniel
    Lenz, Robert
    LANCET NEUROLOGY, 2017, 16 (06) : 425 - 434
  • [49] Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial
    Mullen, Michael
    Jin, Xu Yu
    Child, Anne
    Stuart, A. Graham
    Dodd, Matthew
    Aragon-Martin, Jose Antonio
    Gaze, David
    Kiotsekoglou, Anatoli
    Yuan, Li
    Hu, Jiangting
    Foley, Claire
    Van Dyck, Laura
    Knight, Rosemary
    Clayton, Tim
    Swan, Lorna
    Thomson, John D. R.
    Erdem, Guliz
    Crossman, David
    Flather, Marcus
    LANCET, 2019, 394 (10216) : 2263 - 2270
  • [50] Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial
    Wang, Kay
    Birring, Surinder S.
    Taylor, Kathryn
    Fry, Norman K.
    Hay, Alastair D.
    Moore, Michael
    Jin, Jing
    Perera, Rafael
    Farmer, Andrew
    Little, Paul
    Harrison, Timothy G.
    Mant, David
    Harnden, Anthony
    LANCET RESPIRATORY MEDICINE, 2014, 2 (01) : 35 - 43
12345